246 related articles for article (PubMed ID: 15218223)
1. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
Sharma S; Kaur R; Yadav V; Harjai K; Joshi K
Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
[TBL] [Abstract][Full Text] [Related]
2. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis.
Al-Ssum RM; Harris DM
J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099
[No Abstract] [Full Text] [Related]
3. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection.
Wretlind B; Björklind A; Pavlovskis OR
Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812
[TBL] [Abstract][Full Text] [Related]
4. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
Wretlind B; Pavlovskis OR
Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
Blackwood LL; Stone RM; Iglewski BH; Pennington JE
Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
[TBL] [Abstract][Full Text] [Related]
7. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
[TBL] [Abstract][Full Text] [Related]
8. Determination of the amino acid change responsible for the nontoxic, cross-reactive exotoxin A protein (CRM 66) of Pseudomonas aeruginosa PAO-PR1.
Wick MJ; Iglewski BH
J Bacteriol; 1988 Nov; 170(11):5385-8. PubMed ID: 3141388
[TBL] [Abstract][Full Text] [Related]
9. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15(1):47-50. PubMed ID: 3106228
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors.
Schaible B; Rodriguez J; Garcia A; von Kriegsheim A; McClean S; Hickey C; Keogh CE; Brown E; Schaffer K; Broquet A; Taylor CT
J Infect Dis; 2017 May; 215(9):1459-1467. PubMed ID: 28368464
[TBL] [Abstract][Full Text] [Related]
11. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
[TBL] [Abstract][Full Text] [Related]
12. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice.
Miyazaki S; Matsumoto T; Tateda K; Ohno A; Yamaguchi K
J Med Microbiol; 1995 Sep; 43(3):169-75. PubMed ID: 7650723
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
[No Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa exotoxin A and keratitis in mice.
Pillar CM; Hobden JA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1437-44. PubMed ID: 11980858
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
[TBL] [Abstract][Full Text] [Related]
16. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
[TBL] [Abstract][Full Text] [Related]
17. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa.
Vasil ML; Ogle JW; Grant CC; Vasil AI
Antibiot Chemother (1971); 1987; 39():264-78. PubMed ID: 3118789
[No Abstract] [Full Text] [Related]
18. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
Lory S; Tai PC
Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
[No Abstract] [Full Text] [Related]
19. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease.
Woods DE; Sokol PA
Clin Invest Med; 1986; 9(2):108-12. PubMed ID: 3089661
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.
Jiang M; Yao J; Feng G
PLoS One; 2014; 9(5):e96609. PubMed ID: 24788626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
